The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dairy Crest Group plc

6 Mar 2019 15:20

RNS Number : 0519S
BlackRock Group
06 March 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dairy Crest Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

05 March 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,262,727

5.95%

0

0.00%

(2) Cash-settled derivatives:

 

0

0.00%

162,386

0.10%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

9,262,727

5.95%

162,386

0.10%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p ordinary

Purchase

173

GBP 6.4300

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

06 March 2019

Contact name:

James Michael

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETDMGGFMVVGLZM
Date   Source Headline
31st Jan 201811:43 amRNSTotal Voting Rights & Capital
31st Jan 20187:00 amRNSTrading Update
26th Jan 20182:51 pmRNSDirector/PDMR Shareholding
18th Jan 20183:53 pmRNSDirector and PCA Dealing
17th Jan 20187:00 amRNSExecutive Director Notification
9th Jan 201810:28 amRNSDirector / PDMR Shareholding
3rd Jan 20183:39 pmRNSDirector/PDMR Shareholding
2nd Jan 20189:38 amRNSTotal Voting Rights & Capital
5th Dec 20179:29 amRNSTR-1
30th Nov 201710:43 amRNSTotal Voting Rights & Capital
28th Nov 20177:00 amRNSNon-Executive Director Appointment
22nd Nov 20172:17 pmRNSStandard form for notification of major holdings
20th Nov 201710:40 amRNSDirector/PDMR Shareholding
13th Nov 201710:28 amRNSStandard form for notification of major holdings
9th Nov 20177:00 amRNSInterim Results
3rd Nov 20171:56 pmRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
21st Sep 201712:11 pmRNSTR-1: form for notification of major holdings
18th Sep 20177:00 amRNSTrading Statement
8th Sep 20177:00 amRNSActuarial valuation agreed for the pension fund
4th Sep 20172:37 pmRNSDirector / PDMR Shareholding
31st Aug 20171:42 pmRNSTotal Voting Rights
17th Aug 20172:03 pmRNSDirector / PDMR Shareholding
15th Aug 201710:15 amRNSDirector/PDMR Shareholding
9th Aug 201710:12 amRNSBLOCK LISTING SIX MONTHLY REVIEW
31st Jul 201712:11 pmRNSTotal Voting Rights & Capital
18th Jul 20174:51 pmRNSResults of Annual General Meeting
18th Jul 20177:00 amRNSAGM and Interim Management Statement
7th Jul 20171:36 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
30th Jun 201711:15 amRNSTotal Voting Rights
16th Jun 201710:43 amRNS2017 Annual Report & Accounts & Notice of AGM
2nd Jun 201710:36 amRNSTotal Voting Rights
26th May 20173:54 pmRNSDirector / PDMR Shareholding
19th May 201712:47 pmRNSBlock Listing Six Monthly Review
18th May 20177:00 amRNSPreliminary Results
28th Apr 201710:40 amRNSTotal Voting Rights
12th Apr 201712:02 pmRNSNotification of Major Interest in Shares
31st Mar 20179:21 amRNSTotal Voting Rights & Capital
2nd Mar 20173:16 pmRNSTotal Voting Rights
9th Feb 20177:00 amRNSInterim Management Statement
31st Jan 201711:29 amRNSTotal Voting Rights & Capital
27th Jan 201712:51 pmRNSDirector/PDMR Shareholding
10th Jan 20171:38 pmRNSDirector / PDMR Shareholding
10th Jan 20171:27 pmRNSDirector / PDMR Shareholding
10th Jan 20171:24 pmRNSDirector / PDMR Shareholding
3rd Jan 201710:59 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDairy Crest announces research partnership
30th Nov 201612:58 pmRNSTotal Voting Rights & Capital
24th Nov 20161:02 pmRNSBLOCK LISTING SIX MONTHLY REVIEW

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.